Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07389928

Comprehensive Biomarker ProfiliNg in PatieNts With VEntriCular TachyCardia, PremAtuRe VEntricular Contractions, and AVNRT

To systematically evaluate multiple biomarkers in patients ventricular tachycardia (VT), premature ventricular contractions (PVC), atrioventricular nodal reentrant tachycardia (AVNRT) undergoing catheter ablation to elucidate their mechanistic relevance and predictive value.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 18 years
  • Catheter ablation due to VT, PVC, or AVNRT
  • Written informed consent

Exclusion criteria

  • Infection or inflammatory disease at time of sampling
  • Pregnancy
  • Inability to comply with study procedures
  • Life expectancy < 1 year not due to arrhythmia

Treatment and study plan

Primary outcomes

  1. Association between baseline biomarker profiles and arrhythmia subtype (VT, PVC, AVNRT).

    Time frame: 24 months

Sponsors and collaborators

Lead sponsor

University of Luebeck

Other

Registry information

Official study title

Comprehensive Biomarker ProfiliNg in PatieNts With VEntriCular TachyCardia, PremAtuRe VEntricular Contractions, and AVNRT (CONNECT-CARE)

Acronym: CONNECT-CARE

Important dates

Study start
2026
Primary completion
2030
Study completion
2030
First posted
Feb 5, 2026
Registry last updated
Feb 5, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.